Related content

A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolone and continuous combined estrogen-progestogen treatment

By Conner P.   Christow A.   Kersemaekers W.   Söderqvist G.   Skoog L.   Carlström K.   Tani E.   Mol-Arts M.   Schoultz B. von  

Climacteric, Vol. 7, Iss. 1, 2004-01 ,pp. : 50-58

Informa Healthcare

Access to resources Recommend Favorite

Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens

By Lundström E.   Wilczek B.   von Palffy Z.   Söderqvist G.   von Schoultz B.  

Climacteric, Vol. 4, Iss. 1, 2001-03 ,pp. : 42-48

Informa Healthcare

Access to resources Recommend Favorite

The dilemma of menopause and hormone replacement - a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women

By Castelo-Branco C.   Peralta S.   Ferrer J.   Palacios S.   Cornago S.   Quereda F.  

Climacteric, Vol. 9, Iss. 5, 2006-10 ,pp. : 380-387

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of and satisfaction with complementary therapies and hormone replacement therapy in a specialist menopause clinic

By Vashisht A.   Domoney C. L.   Cronje W.   Studd J. W. W.  

Climacteric, Vol. 4, Iss. 3, 2001-09 ,pp. : 250-256

Informa Healthcare

Access to resources Recommend Favorite

Coronary heart disease and hormone replacement therapy after the menopause

By Hodis H. N.   Mack W. J.  

Climacteric, Vol. 12, Iss. 1, 2009-08 ,pp. : 71-75

Informa Healthcare

Access to resources Recommend Favorite